Interval to surgery after neoadjuvant treatment for colorectal cancer

World Journal of Gastroenterology

Volumn 20, Issue 15, 2014, Pages 4256-4262

  Wasserberg, Nir ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Chemoradiation therapy; Colorectal cancer; Interval to surgery; Neoadjuvant; Rectal cancer; Surgery

Indexed keywords

ANASTOMOSIS LEAKAGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER SURGERY; CHEMORADIOTHERAPY; COLORECTAL CANCER; FIBROSIS; HUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; TREATMENT DURATION; TREATMENT INTERVAL; TREATMENT OUTCOME; TUMOR REGRESSION; ADJUVANT THERAPY; ANAL CANAL; CANCER STAGING; COLORECTAL NEOPLASMS; DISEASE FREE SURVIVAL; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PREOPERATIVE PERIOD; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY;

ANAL CANAL; CHEMORADIOTHERAPY; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PREOPERATIVE PERIOD; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84898841107     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i15.4256     Document Type: Article

References (68)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300 [PMID: 20610543 DOI: 10.3322/caac.20073]
2. Cohen SM, Neugut AI. Adjuvant therapy for rectal cancer in the elderly. Drugs Aging 2004; 21: 437-451 [PMID: 15132712 DOI: 10.2165/00002512-200421070-00003]
3. Cellini F, Valentini V. Current perspectives on preoperative integrated treatments for locally advanced rectal cancer: a review of agreement and controversies. Oncology (Williston Park) 2012; 26: 730-735; 741 [PMID: 22957406]
4. Popek S, Tsikitis VL. Neoadjuvant vs adjuvant pelvic radiotherapy for locally advanced rectal cancer: Which is superior? World J Gastroenterol 2011; 17: 848-854 [PMID: 21412494 DOI: 10.3748/wjg.v17.i7.848]
5. Du CZ, Chen YC, Cai Y, Xue WC, Gu J. Oncologic outcomes of primary and post-irradiated early stage rectal cancer: a retrospective cohort study. World J Gastroenterol 2011; 17: 3229-3234 [PMID: 21912472 DOI: 10.3748/wjg.v17.i27.3229]
6. Petersen SH, Harling H, Kirkeby LT, Wille-Jørgensen P, Mocellin S. Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev 2012; 3: CD004078 [PMID: 22419291 DOI: 10.1002/14651858. CD004078.pub2]
7. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Rectal cancer. Accessed: September, 26, 2013. Available from: URL: http://www.trikobe. org/nccn/guideline/colorectal/english/rectal.pdf3:
8. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CJ. The TME trial after a median followup of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701 [PMID: 17968156 DOI: 10.1097/01. sla.0000257358.56863.ce]
9. Ortholan C, Francois E, Thomas O, Benchimol D, Baulieux J, Bosset JF, Gerard JP. Role of radiotherapy with surgery for T3 and resectable T4 rectal cancer: evidence from randomized trials. Dis Colon Rectum 2006; 49: 302-310 [PMID: 16456638 DOI: 10.1007/s10350-005-0263-x]
10. Kim DW, Kim DY, Kim TH, Jung KH, Chang HJ, Sohn DK, Lim SB, Choi HS, Jeong SY, Park JG. Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer? Cancer 2006; 106: 1694-1700 [PMID: 16532432 DOI: 10.1002/cncr.21794]
11. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740 [PMID: 15496622 DOI: 10.1056/NEJMoa040694]
12. Kim DW, Lim SB, Kim DY, Kim TH, Jung KH, Kim DH, Chang HJ, Sohn DK, Hong CW, Choi HS, Jeong SY, Park JG. Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge. Eur J Surg Oncol 2006; 32: 162-167 [PMID: 16289718 DOI: 10.1016/j.ejso.2005.10.002]
13. Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, Glynne-Jones R, Coco C, Romano M, Mantello G, Palazzi S, Mattia FO, Friso ML, Genovesi D, Vidali C, Gambacorta MA, Buffoli A, Lupattelli M, Favretto MS, La Torre G. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008; 72: 99-107 [PMID: 18407433 DOI: 10.1016/j.ijrobp.2007.12.019]
14. Habr-Gama A, Perez RO, São Julião GP, Proscurshim I, Gama-Rodrigues J. Nonoperative approaches to rectal cancer: a critical evaluation. Semin Radiat Oncol 2011; 21: 234-239 [PMID: 21645869 DOI: 10.1016/j.semradonc.2011.02.010]
15. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006; 333: 779 [PMID: 16984925]
16. Supiot S, Gouraud W, Campion L, Jezéquel P, Buecher B, Charrier J, Heymann MF, Mahé MA, Rio E, Chérel M. Early dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer: a feasibility study. World J Gastroenterol 2013; 19: 3249-3254 [PMID: 23745026 DOI: 10.3748/wjg.v19.i21.3249]
17. Ozden SA, Ozyurt H, Ozgen Z, Kilinc O, Oncel M, Gul AE, Karadayi N, Serakinci N, Kan B, Orun O. Prognostic role of sensitive-to-apoptosis gene expression in rectal cancer. World J Gastroenterol 2011; 17: 4905-4910 [PMID: 22171132 DOI: 10.3748/wjg.v17.i44.4905]
18. Mohiuddin M, Winter K, Mitchell E, Hanna N, Yuen A, Nichols C, Shane R, Hayostek C, Willett C. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 2006; 24: 650-655 [PMID: 16446336 DOI: 10.1200/JCO.2005.03.6095]
19. Wiltshire KL, Ward IG, Swallow C, Oza AM, Cummings B, Pond GR, Catton P, Kim J, Ringash J, Wong CS, Wong R, Siu LL, Moore M, Brierley J. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrencefree survival, disease-free survival, and overall survival. Int J Radiat Oncol Biol Phys 2006; 64: 709-716 [PMID: 16242252 DOI: 10.1016/j.ijrobp.2005.08.012]
20. Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2012; 82: 1367-1375 [PMID: 21775070 DOI: 10.1016/j.ijrobp.2011.05.027]
21. Habr-Gama A, Perez RO, Sabbaga J, Nadalin W, São Julião GP, Gama-Rodrigues J. Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: results of a prospective study using additional chemotherapy during the resting period. Dis Colon Rectum 2009; 52: 1927-1934 [PMID: 19934911 DOI: 10.1007/DCR.0b013e3181ba14ed]
22. Foster JD, Jones EL, Falk S, Cooper EJ, Francis NK. Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature. Dis Colon Rectum 2013; 56: 921-930 [PMID: 23739201 DOI: 10.1097/ DCR.0b013e31828aedcb]
23. Kligerman MM, Urdaneta N, Knowlton A, Vidone R, Hartman PV, Vera R. Preoperative irradiation of rectosigmoid carcinoma including its regional lymph nodes. Am J Roentgenol Radium Ther Nucl Med 1972; 114: 498-503 [PMID: 4622149 DOI: 10.2214/ajr.114.3.498]
24. Rider WD, Palmer JA, Mahoney LJ, Robertson CT. Preoperative irradiation in operable cancer of the rectum: report of the Toronto trial. Can J Surg 1977; 20: 335-338 [PMID: 871980]
25. Higgins GA, Humphrey EW, Dwight RW, Roswit B, Lee LE, Keehn RJ. Preoperative radiation and surgery for cancer of the rectum. Veterans Administration Surgical Oncology Group Trial II. Cancer 1986; 58: 352-359 [PMID: 3521832]
26. Gérard A, Buyse M, Nordlinger B, Loygue J, Pène F, Kempf P, Bosset JF, Gignoux M, Arnaud JP, Desaive C. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988; 208: 606-614 [PMID: 3056288 DOI: 10.1097/00000658-19 8811000-00011]
27. Randomized study on preoperative radiotherapy in rectal carcinoma. Stockholm Colorectal Cancer Study Group. Ann Surg Oncol 1996; 3: 423-430 [PMID: 8876883 DOI: 10.1007/ BF02305759]
28. Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, Souquet JC, Adeleine P, Gerard JP. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999; 17: 2396 [PMID: 10561302]
29. Wang Y, Cummings B, Catton P, Dawson L, Kim J, Ringash J, Wong R, Yi QL, Brierley J. Primary radical external beam radiotherapy of rectal adenocarcinoma: long term outcome of 271 patients. Radiother Oncol 2005; 77: 126-132 [PMID: 16216364 DOI: 10.1016/j.radonc.2005.09.001]
30. Mohiuddin M, Mohiuddin MM, Marks J, Marks G. Future directions in neoadjuvant therapy of rectal cancer: maximizing pathological complete response rates. Cancer Treat Rev 2009; 35: 547-552 [PMID: 19539429 DOI: 10.1016/j.ctrv.2009.05.002]
31. Wong RK, Tandan V, De Silva S, Figueredo A. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2007; (2): CD002102 [PMID: 17443515]
32. Nozue M, Isaka N, Fukao K. Over-expression of vascular endothelial growth factor after preoperative radiation therapy for rectal cancer. Oncol Rep 2001; 8: 1247-1249 [PMID: 11605042]
33. Baeten CI, Castermans K, Lammering G, Hillen F, Wouters BG, Hillen HF, Griffioen AW, Baeten CG. Effects of radiotherapy and chemotherapy on angiogenesis and leukocyte infiltration in rectal cancer. Int J Radiat Oncol Biol Phys 2006; 66: 1219-1227 [PMID: 17145537 DOI: 10.1016/ j.ijrobp.2006.07.1362]
34. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: 19-23 [PMID: 9112145 DOI: 10.1007/ s003840050072]
35. Rödel C, Martus P, Papadoupolos T, Füzesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, Wittekind C. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005; 23: 8688-8696 [PMID: 16246976 DOI: 10.1200/ JCO.2005.02.1329]
36. Sloothaak DA, Geijsen DE, van Leersum NJ, Punt CJ, Buskens CJ, Bemelman WA, Tanis PJ. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br J Surg 2013; 100: 933-939 [PMID: 23536485 DOI: 10.1002/bjs.9112]
37. Kalady MF, de Campos-Lobato LF, Stocchi L, Geisler DP, Dietz D, Lavery IC, Fazio VW. Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg 2009; 250: 582-589 [PMID: 19710605 DOI: 10.1097/SLA.0b013e3181b91e63]
38. Garcia-Aguilar J, Smith DD, Avila K, Bergsland EK, Chu P, Krieg RM. Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg 2011; 254: 97-102 [PMID: 21494121 DOI: 10.1097/SLA.0b013e3182196e1f]
39. Perez RO, Habr-Gama A, São Julião GP, Gama-Rodrigues J, Sousa AH, Campos FG, Imperiale AR, Lynn PB, Proscurshim I, Nahas SC, Ono CR, Buchpiguel CA. Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks? Int J Radiat Oncol Biol Phys 2012; 84: 1159-1165 [PMID: 22580120 DOI: 10.1016/ j.ijrobp.2012.01.096]
40. Tran CL, Udani S, Holt A, Arnell T, Kumar R, Stamos MJ. Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer. Am J Surg 2006; 192: 873-877 [PMID: 17161111 DOI: 10.1016/j.amjsurg.2006.08.061]
41. Lim SB, Choi HS, Jeong SY, Kim DY, Jung KH, Hong YS, Chang HJ, Park JG. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers. Ann Surg 2008; 248: 243-251 [PMID: 18650634 DOI: 10.1097/ SLA.0b013e31817fc2a0]
42. Coucke PA, Notter M, Matter M, Fasolini F, Calmes JM, Schlumpf R, Schwegler N, Stamm B, Phuoc Do H, Bouzourene H. Effect of timing of surgery on survival after preoperative hyperfractionated accelerated radiotherapy (HART) for locally advanced rectal cancer (LARC): is it a matter of days? Acta Oncol 2006; 45: 1086-1093 [PMID: 17118844 DOI: 10.1080/02841 860600891317]
43. Stein DE, Mahmoud NN, Anné PR, Rose DG, Isenberg GA, Goldstein SD, Mitchell E, Fry RD. Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma. Dis Colon Rectum 2003; 46: 448-453 [PMID: 12682535 DOI: 10.1007/s10350-004-6579-0]
44. Moore HG, Gittleman AE, Minsky BD, Wong D, Paty PB, Weiser M, Temple L, Saltz L, Shia J, Guillem JG. Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 2004; 47: 279-286 [PMID: 14991488 DOI: 10.1007/s10350-003-0062-1]
45. Sermier A, Gervaz P, Egger JF, Dao M, Allal AS, Bonet M, Morel P. Lymph node retrieval in abdominoperineal surgical specimen is radiation time-dependent. World J Surg Oncol 2006; 4: 29 [PMID: 16749931 DOI: 10.1186/1477-7819-4-29]
46. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis. Radiology 2004; 232: 773-783 [PMID: 15273331 DOI: 10.1148/radiol.2323031368]
47. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2: 996-999 [PMID: 2430152 DOI: 10.1016/S0140-6736(86)92612-7]
48. Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, Søreide O. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002; 89: 327-334 [PMID: 11872058 DOI: 10.1046/j.0007-1323.2001.02024.x]
49. Wasserberg N, Gutman H. Resection margins in modern rectal cancer surgery. J Surg Oncol 2008; 98: 611-615 [PMID: 19072854 DOI: 10.1002/jso.21036]
50. de Campos-Lobato LF, Stocchi L, da Luz Moreira A, Kalady MF, Geisler D, Dietz D, Lavery IC, Remzi FH, Fazio VW. Downstaging without complete pathologic response after neoadjuvant treatment improves cancer outcomes for cIII but not cII rectal cancers. Ann Surg Oncol 2010; 17: 1758-1766 [PMID: 20131015 DOI: 10.1245/s10434-010-0924-4]
51. Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo LJ, Calvo FA, García-Aguilar J, Glynne-Jones R, Haustermans K, Mohiuddin M, Pucciarelli S, Small W, Suárez J, Theodoropoulos G, Biondo S, Beets-Tan RG, Beets GL. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010; 11: 835-844 [PMID: 20692872 DOI: 10.1016/S1470-2045(10)70172-8]
52. Tulchinsky H, Shmueli E, Figer A, Klausner JM, Rabau M. An interval & gt; 7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and diseasefree survival in patients with locally advanced rectal cancer. Ann Surg Oncol 2008; 15: 2661-2667 [PMID: 18389322 DOI: 10.1245/s10434-008-9892-3]
53. de Campos-Lobato LF, Geisler DP, da Luz Moreira A, Stocchi L, Dietz D, Kalady MF. Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery. J Gastrointest Surg 2011; 15: 444-450 [PMID: 21140237 DOI: 10.1007/s11605-010-1197-8]
54. Wolthuis AM, Penninckx F, Haustermans K, De Hertogh G, Fieuws S, Van Cutsem E, D'Hoore A. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome. Ann Surg Oncol 2012; 19: 2833-2841 [PMID: 22451236 DOI: 10.1245/s10434-012-2327-1]
55. Pach R, Kulig J, Richter P, Gach T, Szura M, Kowalska T. Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer--treatment results at 5-year follow-up. Langenbecks Arch Surg 2012; 397: 801-807 [PMID: 22170083 DOI: 10.1007/s00423-011-0890-8]
56. Glehen O, Chapet O, Adham M, Nemoz JC, Gerard JP. Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer. Br J Surg 2003; 90: 996-998 [PMID: 12905554 DOI: 10.1002/bjs.4162]
57. Supiot S, Bennouna J, Rio E, Meurette G, Bardet E, Buecher B, Dravet F, Le Neel JC, Douillard JY, Mahé MA, Lehur PA. Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer. Colorectal Dis 2006; 8: 430-435 [PMID: 16684088 DOI: 10.1111/j.1463-1318.2006.00990.x]
58. Evans J, Patel U, Brown G. Rectal cancer: primary staging and assessment after chemoradiotherapy. Semin Radiat Oncol 2011; 21: 169-177 [PMID: 21645861 DOI: 10.1016/ j.semradonc.2011.02.002]
59. Kerr SF, Norton S, Glynne-Jones R. Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis. Br J Surg 2008; 95: 1534-1540 [PMID: 18942057 DOI: 10.1002/bjs.6377]
60. Dolinsky CM, Mahmoud NN, Mick R, Sun W, Whittington RW, Solin LJ, Haller DG, Giantonio BJ, O'Dwyer PJ, Rosato EF, Fry RD, Metz JM. Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer. J Surg Oncol 2007; 96: 207-212 [PMID: 17443718 DOI: 10.1002/ jso.20815]
61. Habr-Gama A, Perez RO, Proscurshim I, Nunes Dos Santos RM, Kiss D, Gama-Rodrigues J, Cecconello I. Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys 2008; 71: 1181-1188 [PMID: 18234443 DOI: 10.1016/j.ijrobp.2007.11.035]
62. Veenhof AA, Bloemena E, Engel AF, van der Peet DL, Meijer OW, Cuesta MA. The relationship of histological tumor regression grade (TRG) and two different time intervals to surgery following radiation therapy for locally advanced rectal cancer. Int J Colorectal Dis 2009; 24: 1091-1096 [PMID: 19415307 DOI: 10.1007/s00384-009-0722-2]
63. Ceelen W, Fierens K, Van Nieuwenhove Y, Pattyn P. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: a systematic review and meta-analysis. Int J Cancer 2009; 124: 2966-2972 [PMID: 19253365 DOI: 10.1002/ijc.24247]
64. Påhlman L, Glimelius B. Pre-or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 1990; 211: 187-195 [PMID: 2405793 DOI: 10.1097/00000658-199002000-00011]
65. The Stockholm III Trial on Different Preoperative Radiotherapy Regimens in Rectal Cancer. Accessed: September, 26, 2013. Available from: URL: http://clinicaltrials.gov/show/ NCT00904813
66. Pettersson D, Cedermark B, Holm T, Radu C, Påhlman L, Glimelius B, Martling A. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 2010; 97: 580-587 [PMID: 20155787 DOI: 10.1002/ bjs.6914]
67. Cancer Research United Kingdom. Treatment for rectal cancer. Accessed: September, 26, 2013. Available from: URL: http://www.cancerresearchuk.org/cancer-help/trials
68. STARRCAT Trial: Surgical timing after radiotherapy for rectal cancer. Accessed: September, 26, 2013. Available at: http://www.controlled-trials.com/ISRCTN88843062